These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 10817035)

  • 21. Invasive lobular carcinoma and lobular carcinoma in situ in a phyllodes tumor.
    Shirah GR; Lau SK; Jayaram L; Bouton ME; Patel PN; Komenaka IK
    Breast J; 2011; 17(3):307-9. PubMed ID: 21410591
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
    Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Signet ring lobular carcinoma in situ as a part of the "Rosen Triad" (tubular carcinoma, columnar cell hyperplasia, and lobular carcinoma in situ).
    Bezic J; Gugic D
    Turk Patoloji Derg; 2013; 29(2):134-7. PubMed ID: 23661351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Triad of columnar cell alteration, lobular carcinoma in situ, and tubular carcinoma of the breast.
    Sahoo S; Recant WM
    Breast J; 2005; 11(2):140-2. PubMed ID: 15730461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atypical apocrine adenosis of the breast: a clinicopathologic study of 37 patients with 8.7-year follow-up.
    Seidman JD; Ashton M; Lefkowitz M
    Cancer; 1996 Jun; 77(12):2529-37. PubMed ID: 8640702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mammary carcinoma arising in microglandular adenosis: a case report].
    Charafe-Jauffret E; Jacquemier J; Lelong B; Meynard P; Mathoulin-Portier MP; Houvenhaegel G; Hassoun J
    Ann Pathol; 2001 Oct; 21(5):435-8. PubMed ID: 11852363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current management of lobular carcinoma in situ of the breast.
    Osborne MP; Hoda SA
    Oncology (Williston Park); 1994 Feb; 8(2):45-9; discussion 49, 53-4. PubMed ID: 8167087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does LCIS or ALH without other high-risk lesions diagnosed on core biopsy require surgical excision?
    Dershaw DD
    Breast J; 2003; 9(1):1-3. PubMed ID: 12558662
    [No Abstract]   [Full Text] [Related]  

  • 29. [Carcinoma and fibroadenoma of the breast].
    Morelli A; Díaz L; Vighi S; Romeo L; Gómez Rueda N
    Medicina (B Aires); 1989; 49(6):583-8. PubMed ID: 2487431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lobular intraepithelial neoplasia [lobular carcinoma in situ] with comedo-type necrosis: A clinicopathologic study of 18 cases.
    Fadare O; Dadmanesh F; Alvarado-Cabrero I; Snyder R; Stephen Mitchell J; Tot T; Wang SA; Ghofrani M; Eusebi V; Martel M; Tavassoli FA
    Am J Surg Pathol; 2006 Nov; 30(11):1445-53. PubMed ID: 17063087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topographical, morphological and immunohistochemical characteristics of carcinoma in situ of the breast involving sclerosing adenosis. Two distinct topographical patterns and histological types of carcinoma in situ.
    Moritani S; Ichihara S; Hasegawa M; Endo T; Oiwa M; Shiraiwa M; Nishida C; Morita T; Sato Y; Hayashi T; Kato A; Aoyama H; Yoshikawa K
    Histopathology; 2011 May; 58(6):835-46. PubMed ID: 21401704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carcinoma In Situ Involving Sclerosing Adenosis: Seeking the Salient Histological Characteristics to Prevent Overdiagnosis.
    Cui X; Wei S
    Ann Clin Lab Sci; 2017 Sep; 47(5):529-534. PubMed ID: 29066477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The significance of lobular carcinoma in situ and atypical lobular hyperplasia of the breast.
    Lewis JL; Lee DY; Tartter PI
    Ann Surg Oncol; 2012 Dec; 19(13):4124-8. PubMed ID: 22847126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In situ and invasive lobular neoplasia of the breast.
    Hanby AM; Hughes TA
    Histopathology; 2008 Jan; 52(1):58-66. PubMed ID: 18171417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Natural history and diagnosis of some mammary lesions].
    de Brux J
    Rev Fr Gynecol Obstet; 1973 Jun; 68(6):365-88. PubMed ID: 17474647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Core biopsy of nodular adenosis of the breast can lead to underdiagnosis.
    Westenend PJ; Liem SJ
    AJR Am J Roentgenol; 2001 Jun; 176(6):1596. PubMed ID: 11373239
    [No Abstract]   [Full Text] [Related]  

  • 37. Synchronous lobular carcinoma in situ and invasive lobular cancer: marker or precursor for invasive lobular carcinoma.
    Wallace AS; Xiang D; Hockman L; Arya M; Jeffress J; Wang Z; Dale PS
    Eur J Surg Oncol; 2014 Oct; 40(10):1245-9. PubMed ID: 24857380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spectral morphometric characterization of breast carcinoma cells.
    Barshack I; Kopolovic J; Malik Z; Rothmann C
    Br J Cancer; 1999 Mar; 79(9-10):1613-9. PubMed ID: 10188915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathology of the breast.
    Litzky LA
    Semin Roentgenol; 1993 Jul; 28(3):259-67. PubMed ID: 8211234
    [No Abstract]   [Full Text] [Related]  

  • 40. [A follow-up study about 52 cases of atypical lobular hyperplasia and lobular carcinoma in situ of the breast].
    Li HY; Ren GS; Arnould N; Brettes JP
    Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(13):874-6. PubMed ID: 17953828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.